PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jccsspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
J Cell Commun Signal. 2010 October; 4(3): 131–139.
Published online 2010 September 15. doi:  10.1007/s12079-010-0099-6
PMCID: PMC2948120

The contribution of adhesion signaling to lactogenesis

Abstract

The mammary gland undergoes hormonally controlled cycles of pubertal maturation, pregnancy, lactation, and involution, and these processes rely on complex signaling mechanisms, many of which are controlled by cell–cell and cell–matrix adhesion. The adhesion of epithelial cells to the extracellular matrix initiates signaling mechanisms that have an impact on cell proliferation, survival, and differentiation throughout lactation. The control of integrin expression on the mammary epithelial cells, the composition of the extracellular matrix and the presence of secreted matricellular proteins all contribute to essential adhesion signaling during lactogenesis. In vitro and in vivo studies, including the results from genetically engineered mice, have shed light on the regulation of these processes at the cell and tissue level and have led to increased understanding of the essential signaling components that are regulated in temporal and cell specific manner during lactogenesis. Recent studies suggest that a secreted matricellular protein, CTGF/CCN2, may play a role in lactogenic differentiation through binding to β1 integrin complexes, enhancing the production of extracellular matrix components and contributions to cell adhesion signaling.

Keywords: Lactogenesis, Adhesion, Integrin, Signal transduction, Mammary gland, CTGF, Connective tissue growth factor, CCN2

Mammary gland development

The mammary gland undergoes hormonally controlled cycles of pubertal maturation, pregnancy, lactation, and involution, and these processes rely on complex signaling mechanisms, many of which are controlled by cell–cell and cell–matrix adhesion. In vitro and in vivo studies, including the results from genetically engineered mice, have shed light on the regulation of these processes at the cell and tissue level.

The rudimentary mammary gland, which develops from the mammary placode, is present at birth, but the majority of glandular development is post-natal including hormone-dependent maturation of the gland during puberty, pregnancy and lactation. The mammary gland consists of ducts extending from the nipple through the mammary fat pad to the functional terminal end points referred to as the terminal end buds (TEB) in mice, or alveoli in humans. The TEB is a single bulbous structure that develops into a more complex collection of alveolar structures known as the lobulo-alveolus. In the human, multiple bulbous ends are present on multiple ducts, and these grow and expand during pregnancy (Williams and Daniel 1983). The TEBs consist of two main cellular layers: an inner layer of luminal secretory epithelial cells and an outer layer of contractile myoepithelial cells that surround a central hollow lumen. Surrounding the TEB is a basement membrane layer of highly cross-linked extracellular matrix (ECM) proteins, laminin being the predominant protein. The basement membrane proteins are secreted primarily by the outer layer of myoepithelial cells. Outside of the basement membrane lies the interstitial ECM, which is largely composed of collagen types I and III, as well as other common ECM proteins such as fibronectin, laminin, and tenascin. The invasion of the basement membrane and periductal stroma by the ductal epithelium is a process referred to as branching morphogenesis and is known to involve the breakdown of the ECM proteins by matrix metalloproteinases (MMP) (Wiseman and Werb 2002). MMP-3, specifically, is thought to regulate side branching (Wiseman et al. 2003). This is importat because during pregnancy, lateral buds extend through the main ducts. These buds undergo massive proliferation and subsequent differentiation in order to fill the gland with lobuloalveolar structures that contain the secretory epithelial cells. Later in pregnancy, the alveolar structures increase in number and complexity, and the cells lining the alveoli and small ducts mature, acquiring the ability to secrete milk. The milk secretion, however, is kept in check by high concentrations of circulating progesterone until the initiation of lactation (Turner et al. 1992).

At the onset of pregnancy, the anterior pituitary gland is stimulated to produce prolactin, a single peptide hormone that has two main functions in reproduction. Through the preservation of the corpus luteum, prolactin ensures the secretion of estrogen and progesterone (Gallego et al. 2001), an important event for regulating the morphological changes in the mammary gland during pregnancy. Progesterone receptor studies and knockout in mice revealed that progesterone is required for ductal side branching (Humphreys et al. 1997) (Plaut et al. 1999; Atwood et al. 2000), while prolactin knockout studies revealed that it is required for alveologenesis during pregnancy (Brisken et al. 1999). While the main sources of prolactin are the lactotroph cells of the pituitary, the production of prolactin by mammary epithelial cells has been reported, where it functions as a paracrine mediator of mammary epithelial cell development (Bonnette and Hadsell 2001; Oakes et al. 2006). At parturition, a fall in progesterone levels, accompanied by the maintained elevation of prolactin, leads to secretory cell activation and lactation (Neville et al. 2002).

The establishment of functional alveoli during pregnancy depends on the polarization of the luminal cells and the formation of junctions between them (Barcellos-Hoff et al. 1989). Proteins required for the polarization of the cells and for the formation of tight junctions are regulated, in part, by adhesion-mediated signals. During pregnancy, the myoepithelial cell barrier of the TEB is stretched, thereby allowing many luminal cells to make direct contact with the basement membrane, directly altering cell adhesion and subsequent signaling (Oakes et al. 2006). After parturition, the act of suckling stimulates the release of oxytocin from the posterior pituitary gland, which causes the myoepithelial cell layer to constrict, forcing the milk out of the secretory cells and into the lumen of the alveolus and out through the ductal structures to the nipple. Successful lactation depends upon a pulsatile release of prolactin from the pituitary gland (Wynick et al. 1998). While it is known that prolactin instructs the proliferation and the differentiation of the mammary epithelium through mechanisms specific to the prolactin receptor (Brisken et al. 2002), evidence also suggests that prolactin-mediated signaling, similar to signaling resulting from adhesion to the basement membrane, activates transcriptional programs that are shared between several receptors, such as integrins (Brisken et al. 1999).

Multiple secretory processes are utilized in the epithelial cells of the lactating mammary gland: exocytosis, lipid synthesis and secretion, transmembrane secretion of ions and water, and transcytosis of extra-alveolar proteins such as immunoglobulins and albumins as well as hormones from the interstitial space. The luminal epithelial cells convert precursor proteins into milk components which are transported into the lumen of the alveolar structures. To ensure the properly polarized secretion of milk components, the formation of tight junctions between secretory cells is required. Main components of tight junctions, specifically occludin and zona occludens 1 (ZO-1), are induced by both prolactin and glucocorticoids (Stelwagen et al. 1999). Aside from their contractile function, the physical and paracrine interactions between luminal and myoepithelial cells are critical for maintaining luminal cell polarity, as well as regulating proliferation and apoptosis (Kouros-Mehr et al. 2006). The interaction between the epithelial cells and the stromal cells is also essential for mediating proliferation and survival.

Regulation of milk protein gene expression

During pregnancy, the luminal secretory epithelial cells are induced to produce caseins, the predominant milk proteins in all species, and whey acidic protein (WAP), the primary whey protein. The genes encoding these proteins display both developmental and tissue-specific patterns of expression (Hobbs et al. 1982) and are used as molecular markers of functional differentiation in the mammary gland (Topper and Freeman 1980). The casein genes, including αs1, β, γ, δ, and κ, are encoded by a 250 kb cluster on chromosome 5 of the mouse genome (Rijnkels et al. 1997) with β-casein being expressed at the highest levels in the mouse (Schmidhauser et al. 1992).

The precise contribution of specific transcription factors and their binding sites in the regulation of milk protein gene expression have established that hormonal and developmental regulation of the β-casein gene requires a complex DNA element referred to as a composite response element (CoRE) (Liu et al. 1997; Robinson et al. 1998; Seagroves et al. 1998; Blakely et al. 2006). These CoRE units are defined as a cluster of transcription factor binding sites containing both positive and negative regulatory elements which integrate signal transduction pathways through protein-DNA and protein-protein interactions (Jiang and Levine 1993). The primary factors associated with activation of the β-casein CoRE include signal transducer and activator of transcription 5 (Stat5), glucocorticoid receptor (GR), and CCAAT enhancer binding protein β (C/EBPβ), while Yin Yang-1 (YY-1) associates with the CoRE as a negative regulator of gene expression (Schmitt-Ney et al. 1991; Meier and Groner 1994; Raught et al. 1994; Wakao et al. 1994; Doppler et al. 1995; Raught et al. 1995; Lechner et al. 1997; Seagroves et al. 1998). Interestingly, none of the transcription factors associated with the β-casein CoRE is mammary gland-specific or even restricted to the lactation phase of development.

Adhesion signaling in mammary epithelial cell differentiation and survival

The interaction between mammary epithelial cells (MECs) and the basement membrane (BM) is critical for successful lactogenic differentiation (Fig. 1). While MECs adhere to the BM via various types of ECM receptors, the primary class of receptors is composed of heterodimeric α- and β-chain integrins (Taddei et al. 2003). Other receptors whose specific roles remain undefined include dystroglycan, syndecan, and galactosyl transferase (Streuli 2003). In MECs stimulated to undergo lactogenic differentiation, signals from the matrix are primarily mediated through integrins, since a function-blocking anti-integrin antibody severely diminishes the ability of cells to synthesize β-casein (Streuli et al. 1991). Laminin is the primary component of the BM responsible for the activation of milk protein production, and Muschler et al. (Muschler et al. 1999) determined that signals from laminin for β-casein transcription are inhibited in the presence of function-blocking antibodies against both the α6 and β1 integrin subunits.

Fig. 1
Cell adhesion regulates essential pathways in lactogenesis. The binding of lactogens in conjunction with signals from integrin engagement initiate the critical changes that take place during lactogenic differentiation. The diagram includes the central ...

The extracellular matrix (ECM) induces a complex interaction between bound transcription factors, the basal transcriptional machinery, and a chromosomally integrated template responsive to the acetylation state of the histones at the β-casein enhancer and promoter regions (Myers et al. 1998). There is evidence suggesting that the ECM maintains a high level of histone H4 acetylation upstream of the αs1-casein gene, especially at the level of a distal prolactin and ECM-sensitive enhancer region (Jolivet et al. 2005). Recently, Xu et al. determined that extracellular matrix molecules cooperate with prolactin to induce histone acetylation and the binding of transcription factors as well as the ATP-dependent SWI chromatin remodeling complex to the β-casein promoter (Xu et al. 2007).

Integrin binding to ECM proteins promotes the formation of multi-protein adhesion complexes at the membrane of mammary epithelial cells (Geiger et al. 2001); the complexes include a variety of structural (i.e., vinculin), adaptor (i.e., paxillin, p130cas, parvin, ILK), and kinases (i.e., focal adhesion kinase [FAK], Src) (Cabodi et al. 2006). Complex formation results in integrin clustering and activation of downstream signals primarily involving p130cas, paxillin, ILK, and Src (Cabodi et al. 2006). The focal adhesion complex is formed downstream of the adhesion-induced phosphorylation of FAK-Y397. Recruitment of Src causes tyrosine phosphorylation of additional sites on FAK and the subsequent FAK-mediated phosphorylation of p130cas and paxillin (Schlaepfer et al. 1997). Src contributes to both MEC differentiation and proliferation through its effects on ERα, ErbB, prolactin receptor and p130cas (Kim et al. 2005). FAK activation may also contribute to cell survival by direct activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway (Bouchard et al. 2007).

Detachment from the ECM leads to a type of apoptosis of epithelial cells called anoikis (Frisch and Francis 1994) (Gilmore 2005), thus one of the roles most commonly ascribed to integrin-mediated adhesion is cell survival. Mammary-specific dominant-negative β1 integrin has been shown to result in a decrease in MEC proliferation and increased apoptosis during pregnancy and lactation (Faraldo et al. 2001). Upon the genetic deletion of β1 integrin, MECs undergo cell cycle arrest and glands display defective development in vivo, suggesting that mammary epithelial cell proliferation requires integrin-mediated ECM adhesion (Li et al. 2005), and cells that lack a functional β1 integrin display enhanced apoptosis in in vitro culture (Li et al. 2005). The loss of β1 integrin function contributes to defective milk protein production in mammary epithelial cells, though the exact mechanism involved remains unclear. Mice genetically lacking functional β1 integrin display disrupted alveolar morphology and the absence of Stat5 nuclear translocation in response to prolactin stimulation (Li et al. 2005; Naylor et al. 2005). A study of the mechanism of β1 integrin in vivo by Faraldo et al. (2002) determined that the distruption of β1 integrin function induced precocious dedifferentiation of the secretory epithelium in the mammary gland. This was shown by a premature decrease in β-casein and WAP mRNA levels, accompanied by the inactivation of Stat5 and an upregulation of NF-κB (Faraldo et al. 2002). The link between β1 integrin signaling and prolactin-induced signaling likely involves the integrator of adhesion signaling, Rac1, because integrin-containing adhesion complexes cooperate with Rac1 to allow prolactin-mediated Stat5 nuclear translocation and the resulting transcription of milk proteins (Akhtar and Streuli 2006).

In MECs, overexpression of FAK can prevent anoikis (Gilmore et al. 2000). FAK mammary conditional knockout mice display severe lobulo-alveolar hypoplasia and secretory immaturity during pregnancy and lactation, and the transplantation of FAK knockout MECs into a cleared fat pad of immune-deficient mice also resulted in glands with a disordered myoepithelial and luminal epithelial cell multilayer and abnormal ductal morphogenesis during pregnancy (Nagy et al. 2007; Luo et al. 2009; van Miltenburg et al. 2009). Mammary specific knockout of ILK also resulted in a post-pregnancy defect in alveologenesis; decreased milk fat production and secretion was observed and attributed to reduced lumina, all of which contributed to a lactation defect (Akhtar et al. 2009). These studies revealed a significant decrease in active Rac1 due to ILK deletion and demonstrated that ILK deletion had a more profound effect on milk protein expression that FAK deletion (Akhtar et al. 2009).

A conditional knockout of fibronectin in the mammary gland resulted in decreased β1 integrin and FAK phosphorylation and abrogated alveologenesis and ductal outgrowth in pregnant mice (Liu et al. 2010). The cells of these glands also showed a decrease in phosphorylated Erk1/2, cyclin D1, phosphorylated Stat5, and diminished proliferative capacity (Nagy et al. 2007). Moreover, knockouts of Src blocked ductal development and lactational ability of the mammary gland (Kim et al. 2005) (Watkin et al. 2008). Because of its role in blocking anoikis and its function in adhesion complexes, the role of Akt in lactogenesis has been examined. Expression of constitutively activated Akt1 in the mammary gland resulted in elevated lipid synthesis and secretion due to an AKT-dependent activation of glucose uptake and formation of cytosolic lipid droplets, whereas Akt1 deletion resulted in failure to regulate glucose uptake and lipid synthesis (Schwertfeger et al. 2003; McManaman et al. 2004; Boxer et al. 2006). Mammary gland specific knockout of Akt 2 and Akt 3 revealed that these proteins are critical for the regulation of involution (Maroulakou et al. 2008).

Laminin-1 (LM-1) plays a significant role in the integrin-mediated survival pathway and suppressed anoikis more efficiently than other ECM proteins in MECs (Pullan et al. 1996). Laminin binding to the β1 integrin complex (Mercurio 1995) is directly associated with the induction of lactogenesis and β-casein transcription (Mercurio 1995; Roskelley et al. 1995), but the α integrin partner has not been definitively identified (Klinowska et al. 2001; Chen et al. 2002). The cell-BM interaction is commonly viewed as a positive checkpoint to suppress apoptosis, ensuring that MECs are only maintained within ducts and alveoli (Prince et al. 2002). In addition, MECs proliferate in response to hormonal stimulation only if the adhesion context is permissive (Xie and Haslam 1997). For example, while the estrogen receptor α (ERα) is associated with a highly proliferative MEC phenotype, elevated expression of the ERβ receptor enhances the expression of β1 integrin and promotes the formation of focal adhesions and inhibits MEC proliferation (Lindberg et al. 2010). Furthermore, adhesion to the BM regulates insulin-mediated signaling (Lee and Streuli 1999) (Farrelly et al. 1999) and this is through the RhoA/Rok pathway, which is critical to lactogenic differentiation (Lee et al. 2009).

CCN2 protein contributes to lactogenesis

Connective Tissue Growth Factor (CTGF/CCN2) was identified as a gene highly upregulated in mouse mammary epithelial cells that had been stimulated to undergo lactogenic differentiation, and in primary mammary gland tissue CTGF/CCN2 levels increase during late pregnancy and early lactation (Wang et al. 2008). In HC11 mammary epithelial cells stimulated to undergo lactogenic differentiation, the elevated expression of CTGF/CCN2 was dependent on glucocorticoids, not prolactin or TGFβ (Wang et al. 2008) whereas progesterone elevation, which typically occurs during late pregnancy, regulated CTGF/CCN2 in bovine mammary gland (Forde et al. 2010) (Fig. 2). CCN proteins are matricellular effectors that are secreted into the extracellular environment where they can associate with the cell surface and ECM components (Tettamanti et al. 2006). They function as both as growth factors (Bradham et al. 1991) and as ECM-associated cell adhesion molecules (Kireeva et al. 1997) and exhibit diverse functions regulating many important biological processes including cell attachment (Babic et al. 1999; Chen et al. 2001; Hoshijima et al. 2006), migration (Grzeszkiewicz et al. 2001; Lin et al. 2005), survival (Babic et al. 1999; Leu et al. 2002; Lin et al. 2003), growth (Abreu et al. 2002; Ivkovic et al. 2003), differentiation (Mori et al. 1999; Brigstock 2003) and angiogenesis (Babic et al. 1999; Mo et al. 2002; Lin et al. 2003; Mo and Lau 2006). The CCN proteins (CYR61/CCN1, CTGF/CCN2, NOV/CCN3, and the Wnt-induced secreted proteins 1-3 (Wisp) Wisp1/Elm1/CCN4, Wisp2/Rcop1/CCN5, and Wisp3/CCN6) share a modular structure of an N-terminal signal peptide followed by four homology domains (Perbal 2004). Domain 1 bears sequence homology to IGF binding proteins (IGFBP), domain 2 is homologous to a von Willebrand type C repeat (vWC), domain 3 resembles thrombospondin 1 (TSP-1), and domain 4, the carboxyl-terminal (CT) domain, contains a cysteine knot motif (Bork 1993; Lau and Lam 1999). Tissue-specific CCN isoforms, derived from post-translational processing, proteolytic cleavage between the distinct modules or alternate splicing, have been detected (Perbal 2004). The diverse functions of the CCN family members have been well reviewed elsewhwere (Lau and Lam 1999; Brigstock 2003; Perbal 2004; Brigstock et al. 2005; Kubota and Takigawa 2007; Chen and Lau 2009).

Fig. 2
The contribution of CTGF/CCN2 to lactogenic differentiation. The diagram includes the pathways known to be affected by CTGF/CCN2 during lactogenic differentiation of mammary epithelial cells in primary cells or established cell lines

In the HC11 mouse mammary epithelial cell background, CTGF/CCN2 expression enhanced the early transcription of β-casein in response to lactogenic hormone, and exogenous addition of CTGF/CCN2 contributed to the formation of mammospheres and MCF10A acini, hallmarks of terminal differentiation (Wang et al. 2008; Debnath and Brugge 2005; Morrison et al. 2010). CTGF/CCN2 enhanced the expression of laminin in mammary epithelial cells resulting in a decreased requirement for exogenous laminin for the activation of β-casein transcription (Morrison et al. 2010). CTGF/CCN2 increased expression of fibronectin and stabilized the surface expression of the α6 and β1 integrins; PINCH1 and Rsu1, proteins found in an integrin- ILK-linked protein complex were also elevated (Wang et al. 2008; Morrison et al. 2010). CTGF/CCN2 expression blocked anoikis in the absence of serum and correlated with enhanced focal adhesion formation in HC11 cells. This may have resulted from direct interaction between integrins and secreted or cell-bound CTGF/CCN2, as suggested by studies using α6 and β1 integrin blocking antibodies. Alternatively, the elevation of matrix protein expression may have increased RGD-binding integrin engagement in HC11 cells (Morrison et al. 2010). Syndecan 4, a heparin sulfate proteoglycan, which has been reported to stabilize integrin complexes, including β1 integrin complexes (Morgan et al. 2007; Chen et al. 2004; Kennedy et al. 2007), was also upregulated in CTGF/CCN2-stimulated or -expressing HC11 cells (Cutler and Morrison, unpublished data). Collectively, these results suggest that the mechanism by which CTGF/CCN2 enhances lactogenic differentiation is through stabilization of the interaction between laminin and α6β1 integrin that is required early in the lactogenic differentiation process. Lactogenic differentiation may also depend on expression and stabilization of CTGF/CCN2 -integrin complexes that promote prolactin-induced Stat5 activity (Xu et al. 2007, 2009).

CTGF/CCN2 promotes cell adhesion and migration in a variety of cell types (Kireeva et al. 1997; Babic et al. 1999; Crean et al. 2002) and performs many of its adhesion-related functions through interaction with integrin complexes, as well as through the interaction with heparin sulfate proteoglycans (HSPGs) and the LDL-related protein (LRP) (Chen et al. 2001; Segarini et al. 2001; Ball et al. 2003). CTGF/CCN2 enhanced the levels of β1 integrin on the surface of the cells (Weston et al. 2003; Morrison et al. 2010) and contributed to the adhesion via binding to α6β1 integrin, a common laminin receptor (Chen et al. 2001; Leu et al. 2003; Tong and Brigstock 2006). CTGF/CCN2 also enhanced binding of cells to the common fibronectin receptor, α5β1 integrin (Frazier et al. 1996; Blom et al. 2001; Weston et al. 2003). Disruption of focal adhesions and β1 integrin binding via either FAK or ILK inhibited CTGF/CCN2 expression, suggesting regulation by a pathway dependent on β1 integrin (Graness et al. 2006a, b). CTGF/CCN2 enhanced survival in some cells (Hishikawa et al. 2001; Tong and Brigstock 2006; Wahab et al. 2007). This may have involved the induction of MAP kinase phosphatase-1(Mkp-1) to dephosphorylate MAP kinases p38 and JNK, allowing for accumulation of the anti-apoptotic protein Bcl-2 (Wahab et al. 2007). Because these activities have been observed in mammary epithelial cells expressing CTGF/CCN2, it appears that CTGF/CCN2 may have an essential function in the developing and differentiating mammary gland.

Conclusions

The adhesion of epithelial cells to the extracellular matrix initiates signaling mechanisms that control cell proliferation, survival, and differentiation throughout the phases of mammary gland development. There are multiple levels of control ranging from the control of integrin expression on the mammary epithelial cells to the composition of the extracellular matrix and the presence of secreted matri-cellular proteins. The targeted deletion of specific proteins and the use of three-dimensional in vitro systems are leading the way to increased understanding of the essential signaling components that are regulated in temporal and cell specific manner during development, differentiation and lactogenesis.

Acknowledgements

The authors acknowledge support from the United States Military Cancer Institute.

References

  • Abreu JG, Ketpura NI, et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 2002;4(8):599–604. [PMC free article] [PubMed]
  • Akhtar N, Streuli CH. Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J Cell Biol. 2006;173(5):781–793. [PMC free article] [PubMed]
  • Akhtar N, Marlow R, et al. Molecular dissection of integrin signalling proteins in the control of mammary epithelial development and differentiation. Development. 2009;136(6):1019–1027. [PubMed]
  • Atwood CS, Hovey RC, et al. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol. 2000;167(1):39–52. [PubMed]
  • Babic AM, Chen CC, et al. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol. 1999;19(4):2958–2966. [PMC free article] [PubMed]
  • Ball DK, Rachfal AW, et al. The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol. 2003;176(2):R1–R7. [PubMed]
  • Barcellos-Hoff MH, Aggeler J, et al. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105(2):223–235. [PMC free article] [PubMed]
  • Blakely CM, Stoddard AJ, et al. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006;66(12):6421–6431. [PubMed]
  • Blom IE, Dijk AJ, et al. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant. 2001;16(6):1139–1148. [PubMed]
  • Bonnette SG, Hadsell DL. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology. 2001;142(11):4937–4945. [PubMed]
  • Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993;327(2):125–130. [PubMed]
  • Bouchard V, Demers MJ, et al. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol. 2007;212(3):717–728. [PubMed]
  • Boxer RB, Stairs DB, et al. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 2006;4(6):475–490. [PubMed]
  • Bradham DM, Igarashi A, et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991;114(6):1285–1294. [PMC free article] [PubMed]
  • Brigstock DR. The CCN family: a new stimulus package. J Endocrinol. 2003;178(2):169–175. [PubMed]
  • Brigstock D, Lau L, et al. Report and abstracts of the 3rd International Workshop on the CCN Family of Genes. St Malo, France, 20–23 October 2004. J Clin Pathol. 2005;58(5):463–478. [PMC free article] [PubMed]
  • Brisken C, Kaur S, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210(1):96–106. [PubMed]
  • Brisken C, Socolovsky M, et al. The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium. Proc Natl Acad Sci USA. 2002;99(22):14241–14245. [PubMed]
  • Cabodi S, Tinnirello A, et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res. 2006;66(9):4672–4680. [PubMed]
  • Chen CC, Lau LF (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41(4):771–783 [PMC free article] [PubMed]
  • Chen CC, Chen N, et al. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 2001;276(13):10443–10452. [PubMed]
  • Chen Y, Blom IE, et al. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 2002;62(4):1149–1159. [PubMed]
  • Chen Y, Abraham DJ, et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 2004;15(12):5635–5646. [PMC free article] [PubMed]
  • Crean JK, Finlay D, et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem. 2002;277(46):44187–44194. [PubMed]
  • Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5(9):675–688. [PubMed]
  • Doppler W, Welte T, et al. CCAAT/enhancer-binding protein isoforms beta and delta are expressed in mammary epithelial cells and bind to multiple sites in the beta-casein gene promoter. J Biol Chem. 1995;270(30):17962–17969. [PubMed]
  • Faraldo MM, Deugnier MA, et al. Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep. 2001;2(5):431–437. [PubMed]
  • Faraldo MM, Deugnier MA, et al. Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol Biol Cell. 2002;13(10):3521–3531. [PMC free article] [PubMed]
  • Farrelly N, Lee YJ, et al. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol. 1999;144(6):1337–1348. [PMC free article] [PubMed]
  • Forde N, Spencer TE, et al. Effect of pregnancy and progesterone concentration on expression of genes encoding for transporters or secreted proteins in the bovine endometrium. Physiol Genomics. 2010;41(1):53–62. [PubMed]
  • Frazier K, Williams S, et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107(3):404–411. [PubMed]
  • Frisch SM, Francis H. Disruption of epithelial cell–matrix interactions induces apoptosis. J Cell Biol. 1994;124(4):619–626. [PMC free article] [PubMed]
  • Gallego MI, Binart N, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol. 2001;229(1):163–175. [PubMed]
  • Geiger B, Bershadsky A, et al. Transmembrane crosstalk between the extracellular matrix–cytoskeleton crosstalk. Nat Rev Mol Cell Biol. 2001;2(11):793–805. [PubMed]
  • Gilmore AP. Anoikis. Cell Death Differ. 2005;12(Suppl 2):1473–1477. [PubMed]
  • Gilmore AP, Metcalfe AD, et al. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol. 2000;149(2):431–446. [PMC free article] [PubMed]
  • Graness A, Cicha I, et al. Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int. 2006;69(8):1341–1349. [PubMed]
  • Graness A, Giehl K, et al. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF) Cell Signal. 2006;18(4):433–440. [PubMed]
  • Grzeszkiewicz TM, Kirschling DJ, et al. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem. 2001;276(24):21943–21950. [PubMed]
  • Hishikawa K, Oemar BS, et al. Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem. 2001;276(20):16797–16803. [PubMed]
  • Hobbs AA, Richards DA, et al. Complex hormonal regulation of rat casein gene expression. J Biol Chem. 1982;257(7):3598–3605. [PubMed]
  • Hoshijima M, Hattori T, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett. 2006;580(5):1376–1382. [PubMed]
  • Humphreys RC, Lydon JP, et al. Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997;2(4):343–354. [PubMed]
  • Ivkovic S, Yoon BS, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003;130(12):2779–2791. [PMC free article] [PubMed]
  • Jiang J, Levine M. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell. 1993;72(5):741–752. [PubMed]
  • Jolivet G, Pantano T, et al. Regulation by the extracellular matrix (ECM) of prolactin-induced alpha s1-casein gene expression in rabbit primary mammary cells: role of STAT5, C/EBP, and chromatin structure. J Cell Biochem. 2005;95(2):313–327. [PubMed]
  • Kennedy L, Liu S, et al. CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res. 2007;313(5):952–964. [PubMed]
  • Kim H, Laing M, et al. c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene. 2005;24(36):5629–5636. [PubMed]
  • Kireeva ML, Latinkic BV, et al. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res. 1997;233(1):63–77. [PubMed]
  • Klinowska TC, Alexander CM, et al. Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits. Dev Biol. 2001;233(2):449–467. [PubMed]
  • Kouros-Mehr H, Slorach EM, et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127(5):1041–1055. [PMC free article] [PubMed]
  • Kubota S, Takigawa M. CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis. 2007;10(1):1–11. [PubMed]
  • Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res. 1999;248(1):44–57. [PubMed]
  • Lechner J, Welte T, et al. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J Biol Chem. 1997;272(33):20954–20960. [PubMed]
  • Lee YJ, Streuli CH. Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands. J Biol Chem. 1999;274(32):22401–22408. [PubMed]
  • Lee YJ, Hsu TC, et al. Extracellular matrix controls insulin signaling in mammary epithelial cells through the RhoA/Rok pathway. J Cell Physiol. 2009;220(2):476–484. [PubMed]
  • Leu SJ, Lam SC, et al. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem. 2002;277(48):46248–46255. [PubMed]
  • Leu SJ, Liu Y, et al. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61) J Biol Chem. 2003;278(36):33801–33808. [PubMed]
  • Li N, Zhang Y, et al. Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J. 2005;24(11):1942–1953. [PubMed]
  • Lin CG, Leu SJ, et al. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem. 2003;278(26):24200–24208. [PubMed]
  • Lin CG, Chen CC, et al. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem. 2005;280(9):8229–8237. [PubMed]
  • Lindberg K, Strom A, et al. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells. J Cell Physiol. 2010;222(1):156–167. [PubMed]
  • Liu X, Robinson GW, et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997;11(2):179–186. [PubMed]
  • Liu K, Cheng L et al (2010) Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation. Dev Biol 346(1)11–24 [PMC free article] [PubMed]
  • Luo M, Fan H, et al. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res. 2009;69(2):466–474. [PMC free article] [PubMed]
  • Maroulakou IG, Oemler W, et al. Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol. 2008;217(2):468–477. [PMC free article] [PubMed]
  • McManaman JL, Palmer CA, et al. Regulation of milk lipid formation and secretion in the mouse mammary gland. Adv Exp Med Biol. 2004;554:263–279. [PubMed]
  • Meier VS, Groner B. The nuclear factor YY1 participates in repression of the beta-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction. Mol Cell Biol. 1994;14(1):128–137. [PMC free article] [PubMed]
  • Mercurio AM. Laminin receptors: achieving specificity through cooperation. Trends Cell Biol. 1995;5(11):419–423. [PubMed]
  • Mo FE, Lau LF. The matricellular protein CCN1 is essential for cardiac development. Circ Res. 2006;99(9):961–969. [PMC free article] [PubMed]
  • Mo FE, Muntean AG, et al. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 2002;22(24):8709–8720. [PMC free article] [PubMed]
  • Morgan MR, Humphries MJ, et al. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol. 2007;8(12):957–969. [PMC free article] [PubMed]
  • Mori T, Kawara S, et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol. 1999;181(1):153–159. [PubMed]
  • Morrison BL, Jose CC, et al. Connective tissue growth factor (CTGF/CCN2) enhances lactogenic differentiation of mammary epithelial cells via integrin-mediated cell adhesion. BMC Cell Biol. 2010;11:35. [PMC free article] [PubMed]
  • Muschler J, Lochter A, et al. Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol Biol Cell. 1999;10(9):2817–2828. [PMC free article] [PubMed]
  • Myers CA, Schmidhauser C, et al. Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol Cell Biol. 1998;18(4):2184–2195. [PMC free article] [PubMed]
  • Nagy T, Wei H, et al. Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. J Biol Chem. 2007;282(43):31766–31776. [PubMed]
  • Naylor MJ, Li N, et al. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol. 2005;171(4):717–728. [PMC free article] [PubMed]
  • Neville MC, McFadden TB, et al. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia. 2002;7(1):49–66. [PubMed]
  • Oakes SR, Hilton HN, et al. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 2006;8(2):207. [PMC free article] [PubMed]
  • Perbal B. CCN proteins: multifunctional signalling regulators. Lancet. 2004;363(9402):62–64. [PubMed]
  • Plaut K, Maple R, et al. Progesterone stimulates DNA synthesis and lobulo-alveolar development in mammary glands in ovariectomized mice. J Cell Physiol. 1999;180(2):298–304. [PubMed]
  • Prince JM, Klinowska TC, et al. Cell–matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev Dyn. 2002;223(4):497–516. [PubMed]
  • Pullan S, Wilson J, et al. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci. 1996;109(Pt 3):631–642. [PubMed]
  • Raught B, Khursheed B, et al. YY1 represses beta-casein gene expression by preventing the formation of a lactation-associated complex. Mol Cell Biol. 1994;14(3):1752–1763. [PMC free article] [PubMed]
  • Raught B, Liao WS, et al. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol. 1995;9(9):1223–1232. [PubMed]
  • Rijnkels M, Wheeler DA, et al. Structure and expression of the mouse casein gene locus. Mamm Genome. 1997;8(1):9–15. [PubMed]
  • Robinson GW, Johnson PF, et al. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 1998;12(12):1907–1916. [PubMed]
  • Roskelley CD, Srebrow A, et al. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol. 1995;7(5):736–747. [PMC free article] [PubMed]
  • Schlaepfer DD, Broome MA, et al. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol Cell Biol. 1997;17(3):1702–1713. [PMC free article] [PubMed]
  • Schmidhauser C, Casperson GF, et al. A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression. Mol Biol Cell. 1992;3(6):699–709. [PMC free article] [PubMed]
  • Schmitt-Ney M, Doppler W, et al. Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol. 1991;11(7):3745–3755. [PMC free article] [PubMed]
  • Schwertfeger KL, McManaman JL, et al. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res. 2003;44(6):1100–1112. [PubMed]
  • Seagroves TN, Krnacik S, et al. C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 1998;12(12):1917–1928. [PubMed]
  • Segarini PR, Nesbitt JE, et al. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem. 2001;276(44):40659–40667. [PubMed]
  • Stelwagen K, McFadden HA, et al. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells. Mol Cell Endocrinol. 1999;156(1–2):55–61. [PubMed]
  • Streuli CH. Cell adhesion in mammary gland biology and neoplasia. J Mammary Gland Biol Neoplasia. 2003;8(4):375–381. [PubMed]
  • Streuli CH, Bailey N, et al. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell–cell interaction and morphological polarity. J Cell Biol. 1991;115(5):1383–1395. [PMC free article] [PubMed]
  • Taddei I, Faraldo MM, et al. Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia. 2003;8(4):383–394. [PubMed]
  • Tettamanti G, Malagoli D, et al. Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. Curr Med Chem. 2006;13(23):2737–2750. [PubMed]
  • Tong ZY, Brigstock DR. Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J Endocrinol. 2006;188(3):R1–R8. [PubMed]
  • Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1980;60(4):1049–1106. [PubMed]
  • Turner MD, Rennison ME, et al. Proteins are secreted by both constitutive and regulated secretory pathways in lactating mouse mammary epithelial cells. J Cell Biol. 1992;117(2):269–278. [PMC free article] [PubMed]
  • Miltenburg MH, Lalai R, et al. Complete focal adhesion kinase deficiency in the mammary gland causes ductal dilation and aberrant branching morphogenesis through defects in Rho kinase-dependent cell contractility. FASEB J. 2009;23(10):3482–3493. [PubMed]
  • Wahab N, Cox D, et al. Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1) Biochem J. 2007;406(1):131–138. [PubMed]
  • Wakao H, Gouilleux F, et al. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 1994;13(9):2182–2191. [PubMed]
  • Wang W, Morrison B, et al. Glucocorticoid induced expression of connective tissue growth factor contributes to lactogenic differentiation of mouse mammary epithelial cells. J Cell Physiol. 2008;214(1):38–46. [PubMed]
  • Watkin H, Richert MM, et al. Lactation failure in Src knockout mice is due to impaired secretory activation. BMC Dev Biol. 2008;8:6. [PMC free article] [PubMed]
  • Weston BS, Wahab NA, et al. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J Am Soc Nephrol. 2003;14(3):601–610. [PubMed]
  • Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol. 1983;97(2):274–290. [PubMed]
  • Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 2002;296(5570):1046–1049. [PMC free article] [PubMed]
  • Wiseman BS, Sternlicht MD, et al. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol. 2003;162(6):1123–1133. [PMC free article] [PubMed]
  • Wynick D, Small CJ, et al. Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci USA. 1998;95(21):12671–12676. [PubMed]
  • Xie J, Haslam SZ. Extracellular matrix regulates ovarian hormone-dependent proliferation of mouse mammary epithelial cells. Endocrinology. 1997;138(6):2466–2473. [PubMed]
  • Xu R, Spencer VA, et al. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors. J Biol Chem. 2007;282(20):14992–14999. [PMC free article] [PubMed]
  • Xu R, Nelson CM, et al. Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function. J Cell Biol. 2009;184(1):57–66. [PMC free article] [PubMed]

Articles from Journal of Cell Communication and Signaling are provided here courtesy of The International CCN Society